NCT00653003View on ClinicalTrials.gov

Bioavailability Study of Leflunomide Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
To Determine Bioequivalence Under Fed Conditions
Interventions
DRUG

Leflunomide

tablets, 20mg, single-dose

DRUG

ARAVA

Tablets, 20mg, single-dose

Sponsors
All Listed Sponsors
collaborator

Novum Pharmaceutical Research Services

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT00653003 - Bioavailability Study of Leflunomide Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter